BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grandison GA, Angulo P. Can NASH be diagnosed, graded, and staged noninvasively? Clin Liver Dis. 2012;16:567-585. [PMID: 22824481 DOI: 10.1016/j.cld.2012.05.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Mun H, So ES. Prevalence of Liver Cirrhosis based on the Metabolic Health and Weight Criteria: Report from the Korea National Health and Nutritional Health Examination Survey (KNANES) Data Analysis. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100721] [Reference Citation Analysis]
2 Hu KC, Wang HY, Liu SC, Liu CC, Hung CL, Bair MJ, Liu CJ, Wu MS, Shih SC. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol 2014;20:7718-29. [PMID: 24976709 DOI: 10.3748/wjg.v20.i24.7718] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
3 Tovo CV, de Mattos AZ, Coral GP, Branco FS, Suwa E, de Mattos AA. Noninvasive imaging assessment of non-alcoholic fatty liver disease: Focus on liver scintigraphy. World J Gastroenterol 2015; 21(15): 4432-4439 [PMID: 25914452 DOI: 10.3748/wjg.v21.i15.4432] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
4 Puthenpura MM, Patel V, Fam J, Katz L, Tichansky DS, Myers S. The Use of Transient Elastography Technology in the Bariatric Patient: a Review of the Literature. Obes Surg 2020;30:5108-16. [PMID: 32981002 DOI: 10.1007/s11695-020-05002-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Radmard AR, Poustchi H, Dadgostar M, Yoonessi A, Kooraki S, Jafari E, Hashemi Taheri AP, Malekzadeh R, Merat S. Liver enzyme levels and hepatic iron content in Fatty liver: a noninvasive assessment in general population by T2* mapping. Acad Radiol. 2015;22:714-721. [PMID: 25754799 DOI: 10.1016/j.acra.2015.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Saponaro C, Gaggini M, Gastaldelli A. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. Curr Diab Rep. 2015;15:607. [PMID: 25894944 DOI: 10.1007/s11892-015-0607-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 8.7] [Reference Citation Analysis]
7 Mohamed RZ, Jalaludin MY, Anuar Zaini A. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. J Pediatr Endocrinol Metab 2020;33:247-53. [PMID: 31926095 DOI: 10.1515/jpem-2019-0403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lardi LL, Lul RM, Port GZ, Coral GP, Peres A, Dornelles GP, Branco F, Fernandes S, Leães CG, Mattos AA, Buss C, Tovo CV. Fibromax and inflamatory markers cannot replace liver biopsy in the evaluation of non-alcoholic fatty liver disease. Minerva Gastroenterol (Torino) 2022;68:85-90. [PMID: 32700499 DOI: 10.23736/S2724-5985.20.02746-4] [Reference Citation Analysis]
9 Bannaga AS, Metzger J, Kyrou I, Voigtländer T, Book T, Melgarejo J, Latosinska A, Pejchinovski M, Staessen JA, Mischak H, Manns MP, Arasaradnam RP. Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis-A multicentre study. EBioMedicine 2020;62:103083. [PMID: 33160210 DOI: 10.1016/j.ebiom.2020.103083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Cumberledge J, Angulo P. Editorial: Noninvasive Prediction of Hepatic Steatosis. American Journal of Gastroenterology 2014;109:1415-6. [DOI: 10.1038/ajg.2014.265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int J Mol Sci 2019;20:E2712. [PMID: 31159489 DOI: 10.3390/ijms20112712] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
12 Billeter AT, Müller-Stich BP. [Metabolic surgery]. Chirurg 2019;90:157-70. [PMID: 30734078 DOI: 10.1007/s00104-018-0786-z] [Reference Citation Analysis]
13 Maleki I, Aminafshari MR, Taghvaei T, Hosseini V, Rafiei A, Torabizadeh Z, Barzin M, Orang E. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(35): 12566-12573 [PMID: 25253959 DOI: 10.3748/wjg.v20.i35.12566] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Yoo W, Gjuka D, Stevenson HL, Song X, Shen H, Yoo SY, Wang J, Fallon M, Ioannou GN, Harrison SA, Beretta L. Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid. PLoS One 2017;12:e0189965. [PMID: 29244873 DOI: 10.1371/journal.pone.0189965] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
15 Dvorak K, Hainer R, Petrtyl J, Zeman M, Vareka T, Zak A, Sroubkova R, Svestka T, Vitek L, Bruha R. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;159:442-8. [PMID: 25004910 DOI: 10.5507/bp.2014.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Guo Y, Dong C, Lin H, Zhang X, Wen H, Shen Y, Wang T, Chen S, Liu Y, Chen X. Evaluation of Non-alcoholic Fatty Liver Disease Using Acoustic Radiation Force Impulse Imaging Elastography in Rat Models. Ultrasound Med Biol 2017;43:2619-28. [PMID: 28811064 DOI: 10.1016/j.ultrasmedbio.2017.06.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Angulo P, Bugianesi E, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Barrera F, Haflidadottir S, Day CP, George J. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2013;145:782-9.e4. [PMID: 23860502 DOI: 10.1053/j.gastro.2013.06.057] [Cited by in Crossref: 286] [Cited by in F6Publishing: 258] [Article Influence: 31.8] [Reference Citation Analysis]
18 Schneider M, Benkert T, Solomon E, Nickel D, Fenchel M, Kiefer B, Maier A, Chandarana H, Block KT. Free-breathing fat and R2 * quantification in the liver using a stack-of-stars multi-echo acquisition with respiratory-resolved model-based reconstruction. Magn Reson Med 2020;84:2592-605. [PMID: 32301168 DOI: 10.1002/mrm.28280] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Venkatesh SK, Ehman RL. Magnetic resonance elastography of liver. Magn Reson Imaging Clin N Am. 2014;22:433-446. [PMID: 25086938 DOI: 10.1016/j.mric.2014.05.001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 82] [Article Influence: 14.3] [Reference Citation Analysis]
20 Guo Y, Dong C, Lin H, Zhang X, Wen H, Shen Y, Wang T, Chen S, Liu Y, Chen X. Ex vivo study of acoustic radiation force impulse imaging elastography for evaluation of rat liver with steatosis. Ultrasonics 2017;74:161-6. [DOI: 10.1016/j.ultras.2016.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
21 Yilmaz Y. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther. 2012;36:815-823. [PMID: 22966992 DOI: 10.1111/apt.12046] [Cited by in Crossref: 119] [Cited by in F6Publishing: 124] [Article Influence: 13.2] [Reference Citation Analysis]
22 Ikura Y. Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades. World J Hepatol 2014; 6(12): 894-900 [PMID: 25544876 DOI: 10.4254/wjh.v6.i12.894] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
23 Shetty D, Amarapurkar A, Shukla A. Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis. J Clin Exp Hepatol 2021;11:557-64. [PMID: 34511816 DOI: 10.1016/j.jceh.2020.12.009] [Reference Citation Analysis]
24 Sookoian S, Pirola CJ. Personalizing care for nonalcoholic fatty liver disease patients: what are the research priorities? Per Med 2014;11:735-43. [PMID: 29764046 DOI: 10.2217/pme.14.44] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Nalbantoglu I, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(27): 9026-9037 [PMID: 25083076 DOI: 10.3748/wjg.v20.i27.9026] [Cited by in F6Publishing: 51] [Reference Citation Analysis]
26 Cazzo E, Pareja JC, Chaim EA. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Med J 2017;135:277-95. [DOI: 10.1590/1516-3180.2016.0306311216] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
27 Khov N, Sharma A, Riley TR. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(22): 6821-6825 [PMID: 24944472 DOI: 10.3748/wjg.v20.i22.6821] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
28 Dulger AC, Suvak B, Gonullu H, Gonullu E, Gultepe B, Aydın İ, Batur A, Karadas S, Olmez Ş. High prevalence of chronic hepatitis D virus infection in Eastern Turkey: urbanization of the disease. Arch Med Sci 2016;12:415-20. [PMID: 27186189 DOI: 10.5114/aoms.2015.52030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
29 Caballería L, Saló J, Berzigotti A, Planas R, Vila C, Huertas C, Torres M, Torán P, Caballería J. Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología 2014;37:372-83. [DOI: 10.1016/j.gastrohep.2014.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Shen YN, Yu MX, Gao Q, Li YY, Huang JJ, Sun CM, Qiao N, Zhang HX, Wang H, Lu Q, Wang T. External validation of non-invasive prediction models for identifying ultrasonography-diagnosed fatty liver disease in a Chinese population. Medicine (Baltimore) 2017;96:e7610. [PMID: 28746214 DOI: 10.1097/MD.0000000000007610] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
31 Bazick J, Donithan M, Neuschwander-Tetri BA, Kleiner D, Brunt EM, Wilson L, Doo E, Lavine J, Tonascia J, Loomba R. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. Diabetes Care. 2015;38:1347-1355. [PMID: 25887357 DOI: 10.2337/dc14-1239] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 14.4] [Reference Citation Analysis]
32 Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2014;20:475-485. [PMID: 24574716 DOI: 10.3748/wpg.v20.i2.475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Tovo CV, Villela-Nogueira CA, Leite NC, Panke CL, Port GZ, Fernandes S, Buss C, Coral GP, Cardoso AC, Cravo CM, Calçado FL, Rezende GFM, Ferreira FC, Araujo-Neto JM, Perez RM, Moraes-Coelho HS, de Mattos AA. Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 2019;18:445-9. [PMID: 31031166 DOI: 10.1016/j.aohep.2018.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
34 Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014; 20(2): 475-485 [PMID: 24574716 DOI: 10.3748/wjg.v20.i2.475] [Cited by in CrossRef: 256] [Cited by in F6Publishing: 235] [Article Influence: 32.0] [Reference Citation Analysis]
35 Blais P, Husain N, Kramer JR, Kowalkowski M, El-Serag H, Kanwal F. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol 2015;110:10-4. [PMID: 24890441 DOI: 10.1038/ajg.2014.134] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 8.6] [Reference Citation Analysis]
36 Gunn NT, Shiffman ML. The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom. Clin Liver Dis 2018;22:109-19. [PMID: 29128050 DOI: 10.1016/j.cld.2017.08.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
37 Manickam P, Sudhakar R. Dyslipidemia and non-alcoholic fatty liver disease. Dig Dis Sci. 2013;58:1435. [PMID: 23508978 DOI: 10.1007/s10620-013-2577-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Fielding CM, Angulo P. Hepatic steatosis and steatohepatitis: Are they really two distinct entities? Curr Hepatol Rep 2014;13:151-8. [PMID: 24977111 DOI: 10.1007/s11901-014-0227-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
39 Yang J, Lin L, Xue E, Hong D, Yang Y, Xu M, Chen Z. Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging? Anal Cell Pathol (Amst) 2019;2019:2013674. [PMID: 31011515 DOI: 10.1155/2019/2013674] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Franco I, Bianco A, Mirizzi A, Campanella A, Bonfiglio C, Sorino P, Notarnicola M, Tutino V, Cozzolongo R, Giannuzzi V, Aballay LR, Buongiorno C, Bruno I, Osella AR. Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial. Nutrients 2020;13:E66. [PMID: 33379253 DOI: 10.3390/nu13010066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
41 Graeter T, Niedermayer PC, Mason RA, Oeztuerk S, Haenle MM, Koenig W, Boehm BO, Kratzer W. Coffee consumption and NAFLD: a community based study on 1223 subjects. BMC Res Notes. 2015;8:640. [PMID: 26530296 DOI: 10.1186/s13104-015-1645-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
42 Cazzo E, de Felice Gallo F, Pareja JC, Chaim EA. Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation. Obes Surg 2014;24:666-8. [PMID: 24415281 DOI: 10.1007/s11695-014-1183-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
43 Rajesh Y, Sarkar D. Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1290. [PMID: 32443737 DOI: 10.3390/cancers12051290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
44 Schuppan D, Schattenberg JM. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol. 2013;28 Suppl 1:68-76. [PMID: 23855299 DOI: 10.1111/jgh.12212] [Cited by in Crossref: 148] [Cited by in F6Publishing: 145] [Article Influence: 18.5] [Reference Citation Analysis]
45 Zhou Y, Orešič M, Leivonen M, Gopalacharyulu P, Hyysalo J, Arola J, Verrijken A, Francque S, Van Gaal L, Hyötyläinen T, Yki-järvinen H. Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites. Clinical Gastroenterology and Hepatology 2016;14:1463-1472.e6. [DOI: 10.1016/j.cgh.2016.05.046] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 10.7] [Reference Citation Analysis]
46 Sepulveda-Villegas M, Roman S, Rivera-Iñiguez I, Ojeda-Granados C, Gonzalez-Aldaco K, Torres-Reyes LA, Jose-Abrego A, Panduro A. High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population. PLoS One 2019;14:e0208926. [PMID: 30608932 DOI: 10.1371/journal.pone.0208926] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]